Brief: Metagenomi Inc - MGX-001 Demonstrated Curative FVIII Activity In Non-Human Primates
11/11/2025 21:59
Nov 12 (Reuters) - Metagenomi Inc MGX.O: METAGENOMI INC -MGX-001 DEMONSTRATED CURATIVE FVIII ACTIVITY IN NON-HUMAN PRIMATES METAGENOMI: PRE-IND REGULATORY MEETING EXPECTED IN Q4 2025 WITH IND & CLINICAL TRIAL APPLICATION SUBMISSIONS EXPECTED IN 4Q 2026 Source text: ID:nGNX3Qp3Pr Further company coverage: MGX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metagenomi Therapeutics
See all newsMetagenomi Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Metagenomi Q2 net loss widens cash runway seen through 2027
Metagenomi Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Metagenomi Announces Corporate Name Change To Metagenomi Therapeutics, Inc. And Highlights Recent Business Milestones And 2026 Corporate Outlook
U.S. RESEARCH ROUNDUP- Autodesk, Crowdstrike, Zscaler